Table 1. Therapeutic Recombinant Protein Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Therapeutic Recombinant Protein Market Restraints

Table 3. Therapeutic Recombinant Protein Market Trends

Table 4. Therapeutic Recombinant Protein Industry Policy

Table 5. Global Therapeutic Recombinant Protein Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Therapeutic Recombinant Protein Revenue Market Share by Company (2018-2023)

Table 7. Global Therapeutic Recombinant Protein Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Therapeutic Recombinant Protein Mergers & Acquisitions, Expansion Plans

Table 9. Global Therapeutic Recombinant Protein Manufacturers Product Type

Table 10. China Therapeutic Recombinant Protein Revenue by Company (2018-2023) & (US$ million)

Table 11. China Therapeutic Recombinant Protein Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Therapeutic Recombinant Protein Upstream (Raw Materials)

Table 13. Global Therapeutic Recombinant Protein Typical Customers

Table 14. Therapeutic Recombinant Protein Typical Distributors

Table 15. By Type, Global Therapeutic Recombinant Protein Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Therapeutic Recombinant Protein Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Therapeutic Recombinant Protein Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Therapeutic Recombinant Protein Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Therapeutic Recombinant Protein Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Therapeutic Recombinant Protein Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Therapeutic Recombinant Protein Revenue Market Share, 2018-2029

Table 22. Abcam Company Information, Head Office, Market Area and Industry Position

Table 23. Abcam Company Profile and Main Business

Table 24. Abcam Therapeutic Recombinant Protein Models, Specifications and Application

Table 25. Abcam Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 26. Abcam Recent Developments

Table 27. HALIX Company Information, Head Office, Market Area and Industry Position

Table 28. HALIX Company Profile and Main Business

Table 29. HALIX Therapeutic Recombinant Protein Models, Specifications and Application

Table 30. HALIX Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 31. HALIX Recent Developments

Table 32. Avantor Company Information, Head Office, Market Area and Industry Position

Table 33. Avantor Company Profile and Main Business

Table 34. Avantor Therapeutic Recombinant Protein Models, Specifications and Application

Table 35. Avantor Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 36. Avantor Recent Developments

Table 37. Miltenyi Biotec Company Information, Head Office, Market Area and Industry Position

Table 38. Miltenyi Biotec Company Profile and Main Business

Table 39. Miltenyi Biotec Therapeutic Recombinant Protein Models, Specifications and Application

Table 40. Miltenyi Biotec Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 41. Miltenyi Biotec Recent Developments

Table 42. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 43. Thermo Fisher Scientific Company Profile and Main Business

Table 44. Thermo Fisher Scientific Therapeutic Recombinant Protein Models, Specifications and Application

Table 45. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 46. Thermo Fisher Scientific Recent Developments

Table 47. Bio-Techne Corporation Company Information, Head Office, Market Area and Industry Position

Table 48. Bio-Techne Corporation Company Profile and Main Business

Table 49. Bio-Techne Corporation Therapeutic Recombinant Protein Models, Specifications and Application

Table 50. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 51. Bio-Techne Corporation Recent Developments

Table 52. Merck Company Information, Head Office, Market Area and Industry Position

Table 53. Merck Company Profile and Main Business

Table 54. Merck Therapeutic Recombinant Protein Models, Specifications and Application

Table 55. Merck Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 56. Merck Recent Developments

Table 57. ACROBiosystems Company Information, Head Office, Market Area and Industry Position

Table 58. ACROBiosystems Company Profile and Main Business

Table 59. ACROBiosystems Therapeutic Recombinant Protein Models, Specifications and Application

Table 60. ACROBiosystems Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 61. ACROBiosystems Recent Developments

Table 62. Abnova Company Information, Head Office, Market Area and Industry Position

Table 63. Abnova Company Profile and Main Business

Table 64. Abnova Therapeutic Recombinant Protein Models, Specifications and Application

Table 65. Abnova Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 66. Abnova Recent Developments

Table 67. Eurogentec (Kaneka Corporation) Company Information, Head Office, Market Area and Industry Position

Table 68. Eurogentec (Kaneka Corporation) Company Profile and Main Business

Table 69. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Models, Specifications and Application

Table 70. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 71. Eurogentec (Kaneka Corporation) Recent Developments

Table 72. Cytiva (Danaher ) Company Information, Head Office, Market Area and Industry Position

Table 73. Cytiva (Danaher ) Company Profile and Main Business

Table 74. Cytiva (Danaher ) Therapeutic Recombinant Protein Models, Specifications and Application

Table 75. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 76. Cytiva (Danaher ) Recent Developments

Table 77. Reprocell Company Information, Head Office, Market Area and Industry Position

Table 78. Reprocell Company Profile and Main Business

Table 79. Reprocell Therapeutic Recombinant Protein Models, Specifications and Application

Table 80. Reprocell Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 81. Reprocell Recent Developments

Table 82. GenScript Company Information, Head Office, Market Area and Industry Position

Table 83. GenScript Company Profile and Main Business

Table 84. GenScript Therapeutic Recombinant Protein Models, Specifications and Application

Table 85. GenScript Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 86. GenScript Recent Developments

Table 87. BPS Bioscience Company Information, Head Office, Market Area and Industry Position

Table 88. BPS Bioscience Company Profile and Main Business

Table 89. BPS Bioscience Therapeutic Recombinant Protein Models, Specifications and Application

Table 90. BPS Bioscience Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 91. BPS Bioscience Recent Developments

Table 92. Sino Biological Company Information, Head Office, Market Area and Industry Position

Table 93. Sino Biological Company Profile and Main Business

Table 94. Sino Biological Therapeutic Recombinant Protein Models, Specifications and Application

Table 95. Sino Biological Therapeutic Recombinant Protein Revenue and Gross Margin, 2018-2023

Table 96. Sino Biological Recent Developments

List of Figure

Figure 1. Therapeutic Recombinant Protein Picture

Figure 2. Global Therapeutic Recombinant Protein Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Therapeutic Recombinant Protein Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Therapeutic Recombinant Protein Market Share of Global

Figure 5. Global Therapeutic Recombinant Protein Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Therapeutic Recombinant Protein Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Therapeutic Recombinant Protein Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Therapeutic Recombinant Protein Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Therapeutic Recombinant Protein Industry Chain

Figure 10. Hormones

Figure 11. Blood Clotting Factors

Figure 12. Cytokines

Figure 13. Enzymes

Figure 14. Fusion Proteins

Figure 15. Others

Figure 16. By Type, Global Therapeutic Recombinant Protein Revenue, 2018-2029, US$ Million

Figure 17. By Type, Global Therapeutic Recombinant Protein Revenue Market Share, 2018-2029

Figure 18. Pharmaceutical Company

Figure 19. Research Institute

Figure 20. Others

Figure 21. By Application, Global Therapeutic Recombinant Protein Revenue, 2018-2029, US$ Million

Figure 22. By Application, Global Therapeutic Recombinant Protein Revenue Market Share, 2018-2029

Figure 23. By Region, Global Therapeutic Recombinant Protein Revenue Market Share, 2018-2029

Figure 24. North America Therapeutic Recombinant Protein Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, North America Therapeutic Recombinant Protein Revenue Market Share, 2018-2023

Figure 26. Europe Therapeutic Recombinant Protein Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, Europe Therapeutic Recombinant Protein Revenue Market Share, 2018-2023

Figure 28. Asia Pacific Therapeutic Recombinant Protein Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country/Region, Asia Pacific Therapeutic Recombinant Protein Revenue Market Share, 2018-2023

Figure 30. South America Therapeutic Recombinant Protein Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. By Country, South America Therapeutic Recombinant Protein Revenue Market Share, 2018-2023

Figure 32. Middle East & Africa Therapeutic Recombinant Protein Revenue & Forecasts, 2018-2029, US$ Million

Figure 33. U.S. Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, U.S. Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 35. By Type, U.S. Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 36. By Application, U.S. Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 37. Europe Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, Europe Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 39. By Type, Europe Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 40. By Application, Europe Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 41. China Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, China Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 43. By Type, China Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 44. By Application, China Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 45. Japan Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, Japan Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 47. By Type, Japan Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 48. By Application, Japan Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 49. South Korea Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, South Korea Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 51. By Type, South Korea Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 52. By Application, South Korea Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 53. Southeast Asia Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, Southeast Asia Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 55. By Type, Southeast Asia Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 56. By Application, Southeast Asia Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 57. India Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, India Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 59. By Type, India Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 60. By Application, India Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 61. Middle East & Asia Therapeutic Recombinant Protein Revenue, 2018-2029, (US$ Million)

Figure 62. By Company, Middle East & Asia Therapeutic Recombinant Protein Market Share, 2018-2023

Figure 63. By Type, Middle East & Asia Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 64. By Application, Middle East & Asia Therapeutic Recombinant Protein Revenue Market Share, 2022 VS 2029

Figure 65. Research Methodology

Figure 66. Breakdown of Primary Interviews

Figure 67. Bottom-up Approaches

Figure 68. Top-down Approaches